Regulatory Action Against Genesys International
Genesys International, listed on BSE under the symbol GENESYS, has received regulatory notices from both BSE and NSE dated May 27, 2026. The stock exchanges flagged non-compliance with provisions of Regulation 17(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
In response to the non-compliance, each exchange has imposed a fine of Rs 4,18,900. The combined penalty amount totals Rs 8,38,000 across both BSE and NSE.
About Regulation 17(1)
Regulation 17(1) of the SEBI LODR Regulations governs board composition requirements for listed companies. It mandates specific conditions regarding the size and composition of the board of directors, including requirements for independent directors, executive directors, and adherence to corporate governance standards. Failure to maintain the required board structure can result in regulatory penalties being imposed by the stock exchanges.
Implications for GENESYS Shareholders
The regulatory action highlights the importance of compliance with SEBI's continuous listing obligations. While the fine represents a financial implication for the company, it does not directly impact the company's operational activities. Investors tracking GENESYS stock on BSE or NSE should note that non-compliance issues, if unresolved, could lead to additional penalties or restrictions on further issuances.
The company is expected to address the compliance gaps and communicate corrective measures to the stock exchanges as per SEBI guidelines.
Summary of Penalty Details
| Exchange | Fine Amount |
|---|---|
| BSE | Rs 4,18,900 |
| NSE | Rs 4,18,900 |
| Total | Rs 8,38,000 |
This report is based solely on publicly available corporate filings and does not constitute financial advice. Investors are advised to review official exchange communications and consult a SEBI-registered advisory before making any investment decisions.